{"id":2697,"date":"2023-01-16T14:00:23","date_gmt":"2023-01-16T19:00:23","guid":{"rendered":"https:\/\/fifarma.org\/?post_type=publicaciones&p=2697"},"modified":"2025-06-18T16:44:33","modified_gmt":"2025-06-18T21:44:33","slug":"good-regulatory-practices-enabling-regulatory-efficiencies-to-deliver-medicines-in-a-timely-manner-to-latin-america-and-the-caribbean","status":"publish","type":"publicaciones","link":"https:\/\/fifarma.org\/pt\/publicaciones\/good-regulatory-practices-enabling-regulatory-efficiencies-to-deliver-medicines-in-a-timely-manner-to-latin-america-and-the-caribbean\/","title":{"rendered":"Good Regulatory Practices: Enabling regulatory efficiencies to deliver medicines in a timely manner to Latin America and the Caribbean"},"content":{"rendered":"

FIFARMA members represent the innovative pharmaceutical industry and country trade associations in the Latin American and Caribbean Region. FIFARMA is fully supportive of the World HealthOrganization (WHO)Triple Billion Targets of 1 billion more people benefitting from universal health coverage; 1 billion more people better protected from health emergencies and 1 billion more people enjoying better health and well-being. FIFARMA is committed to engage in the development of policies that foster ecosystems that promotes innovation and the sustainability of health systems in the benefit of patients in Latin America and the Caribbean.<\/p>\n\n\n\n

Preview<\/a><\/div>\n\n\n
English<\/a><\/div>\n\n
2021<\/a><\/div>\n\n
Quest\u00f5es regulat\u00f3rias<\/a><\/div>\n
\n\n\t\t\n
    \n\t\t\t <\/ul>\n <\/div>","protected":false},"author":24,"parent":0,"template":"","ano":[48],"idioma":[45],"etiquetas-publicacion":[39],"categoria-publicacion":[36],"class_list":["post-2697","publicaciones","type-publicaciones","status-publish","hentry","ano-48","idioma-english","etiquetas-publicacion-asuntos-regulatorios","categoria-publicacion-position-paper"],"yoast_head":"\nGood Regulatory Practices: Enabling regulatory efficiencies to deliver medicines in a timely manner to Latin America and the Caribbean - FIFARMA<\/title>\n<meta name=\"description\" content=\"FIFARMA members represent the innovative pharmaceutical industry and country trade associations in the Latin American and Caribbean Region. FIFARMA is fully supportive of the World HealthOrganization (WHO)Triple Billion Targets of 1 billion more people benefitting from universal health coverage; 1 billion more people better protected from health emergencies and 1 billion more people enjoying better health and well-being. FIFARMA is committed to engage in the development of policies that foster ecosystems that promotes innovation and the sustainability of health systems in the benefit of patients in Latin America and the Caribbean.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fifarma.org\/pt\/publicacoes\/good-regulatory-practices-enabling-regulatory-efficiencies-to-deliver-medicines-in-a-timely-manner-to-latin-america-and-the-caribbean\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Good Regulatory Practices: Enabling regulatory efficiencies to deliver medicines in a timely manner to Latin America and the Caribbean\" \/>\n<meta property=\"og:description\" content=\"FIFARMA members represent the innovative pharmaceutical industry and country trade associations in the Latin American and Caribbean Region. FIFARMA is fully supportive of the World HealthOrganization (WHO)Triple Billion Targets of 1 billion more people benefitting from universal health coverage; 1 billion more people better protected from health emergencies and 1 billion more people enjoying better health and well-being. FIFARMA is committed to engage in the development of policies that foster ecosystems that promotes innovation and the sustainability of health systems in the benefit of patients in Latin America and the Caribbean.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fifarma.org\/pt\/publicacoes\/good-regulatory-practices-enabling-regulatory-efficiencies-to-deliver-medicines-in-a-timely-manner-to-latin-america-and-the-caribbean\/\" \/>\n<meta property=\"og:site_name\" content=\"FIFARMA\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-18T21:44:33+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/good-regulatory-practices-enabling-regulatory-efficiencies-to-deliver-medicines-in-a-timely-manner-to-latin-america-and-the-caribbean\\\/\",\"url\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/good-regulatory-practices-enabling-regulatory-efficiencies-to-deliver-medicines-in-a-timely-manner-to-latin-america-and-the-caribbean\\\/\",\"name\":\"Good Regulatory Practices: Enabling regulatory efficiencies to deliver medicines in a timely manner to Latin America and the Caribbean - FIFARMA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#website\"},\"datePublished\":\"2023-01-16T19:00:23+00:00\",\"dateModified\":\"2025-06-18T21:44:33+00:00\",\"description\":\"FIFARMA members represent the innovative pharmaceutical industry and country trade associations in the Latin American and Caribbean Region. FIFARMA is fully supportive of the World HealthOrganization (WHO)Triple Billion Targets of 1 billion more people benefitting from universal health coverage; 1 billion more people better protected from health emergencies and 1 billion more people enjoying better health and well-being. FIFARMA is committed to engage in the development of policies that foster ecosystems that promotes innovation and the sustainability of health systems in the benefit of patients in Latin America and the Caribbean.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/good-regulatory-practices-enabling-regulatory-efficiencies-to-deliver-medicines-in-a-timely-manner-to-latin-america-and-the-caribbean\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/good-regulatory-practices-enabling-regulatory-efficiencies-to-deliver-medicines-in-a-timely-manner-to-latin-america-and-the-caribbean\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/good-regulatory-practices-enabling-regulatory-efficiencies-to-deliver-medicines-in-a-timely-manner-to-latin-america-and-the-caribbean\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/fifarma.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Publicaciones\",\"item\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Good Regulatory Practices: Enabling regulatory efficiencies to deliver medicines in a timely manner to Latin America and the Caribbean\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#website\",\"url\":\"https:\\\/\\\/fifarma.org\\\/\",\"name\":\"FIFARMA\",\"description\":\"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica\",\"publisher\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fifarma.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#organization\",\"name\":\"Fifarma\",\"alternateName\":\"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica\",\"url\":\"https:\\\/\\\/fifarma.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/logo-fifarma.png\",\"contentUrl\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/logo-fifarma.png\",\"width\":195,\"height\":39,\"caption\":\"Fifarma\"},\"image\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Good Regulatory Practices: Enabling regulatory efficiencies to deliver medicines in a timely manner to Latin America and the Caribbean - FIFARMA","description":"FIFARMA members represent the innovative pharmaceutical industry and country trade associations in the Latin American and Caribbean Region. FIFARMA is fully supportive of the World HealthOrganization (WHO)Triple Billion Targets of 1 billion more people benefitting from universal health coverage; 1 billion more people better protected from health emergencies and 1 billion more people enjoying better health and well-being. FIFARMA is committed to engage in the development of policies that foster ecosystems that promotes innovation and the sustainability of health systems in the benefit of patients in Latin America and the Caribbean.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fifarma.org\/pt\/publicacoes\/good-regulatory-practices-enabling-regulatory-efficiencies-to-deliver-medicines-in-a-timely-manner-to-latin-america-and-the-caribbean\/","og_locale":"pt_BR","og_type":"article","og_title":"Good Regulatory Practices: Enabling regulatory efficiencies to deliver medicines in a timely manner to Latin America and the Caribbean","og_description":"FIFARMA members represent the innovative pharmaceutical industry and country trade associations in the Latin American and Caribbean Region. FIFARMA is fully supportive of the World HealthOrganization (WHO)Triple Billion Targets of 1 billion more people benefitting from universal health coverage; 1 billion more people better protected from health emergencies and 1 billion more people enjoying better health and well-being. FIFARMA is committed to engage in the development of policies that foster ecosystems that promotes innovation and the sustainability of health systems in the benefit of patients in Latin America and the Caribbean.","og_url":"https:\/\/fifarma.org\/pt\/publicacoes\/good-regulatory-practices-enabling-regulatory-efficiencies-to-deliver-medicines-in-a-timely-manner-to-latin-america-and-the-caribbean\/","og_site_name":"FIFARMA","article_modified_time":"2025-06-18T21:44:33+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. tempo de leitura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fifarma.org\/publicaciones\/good-regulatory-practices-enabling-regulatory-efficiencies-to-deliver-medicines-in-a-timely-manner-to-latin-america-and-the-caribbean\/","url":"https:\/\/fifarma.org\/publicaciones\/good-regulatory-practices-enabling-regulatory-efficiencies-to-deliver-medicines-in-a-timely-manner-to-latin-america-and-the-caribbean\/","name":"Good Regulatory Practices: Enabling regulatory efficiencies to deliver medicines in a timely manner to Latin America and the Caribbean - FIFARMA","isPartOf":{"@id":"https:\/\/fifarma.org\/#website"},"datePublished":"2023-01-16T19:00:23+00:00","dateModified":"2025-06-18T21:44:33+00:00","description":"FIFARMA members represent the innovative pharmaceutical industry and country trade associations in the Latin American and Caribbean Region. FIFARMA is fully supportive of the World HealthOrganization (WHO)Triple Billion Targets of 1 billion more people benefitting from universal health coverage; 1 billion more people better protected from health emergencies and 1 billion more people enjoying better health and well-being. FIFARMA is committed to engage in the development of policies that foster ecosystems that promotes innovation and the sustainability of health systems in the benefit of patients in Latin America and the Caribbean.","breadcrumb":{"@id":"https:\/\/fifarma.org\/publicaciones\/good-regulatory-practices-enabling-regulatory-efficiencies-to-deliver-medicines-in-a-timely-manner-to-latin-america-and-the-caribbean\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fifarma.org\/publicaciones\/good-regulatory-practices-enabling-regulatory-efficiencies-to-deliver-medicines-in-a-timely-manner-to-latin-america-and-the-caribbean\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fifarma.org\/publicaciones\/good-regulatory-practices-enabling-regulatory-efficiencies-to-deliver-medicines-in-a-timely-manner-to-latin-america-and-the-caribbean\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/fifarma.org\/"},{"@type":"ListItem","position":2,"name":"Publicaciones","item":"https:\/\/fifarma.org\/publicaciones\/"},{"@type":"ListItem","position":3,"name":"Good Regulatory Practices: Enabling regulatory efficiencies to deliver medicines in a timely manner to Latin America and the Caribbean"}]},{"@type":"WebSite","@id":"https:\/\/fifarma.org\/#website","url":"https:\/\/fifarma.org\/","name":"FIFARMA","description":"Federa\u00e7\u00e3o Latino-Americana da Ind\u00fastria Farmac\u00eautica","publisher":{"@id":"https:\/\/fifarma.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fifarma.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/fifarma.org\/#organization","name":"Fifarma","alternateName":"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica","url":"https:\/\/fifarma.org\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/fifarma.org\/#\/schema\/logo\/image\/","url":"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/logo-fifarma.png","contentUrl":"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/logo-fifarma.png","width":195,"height":39,"caption":"Fifarma"},"image":{"@id":"https:\/\/fifarma.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/publicaciones\/2697","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/publicaciones"}],"about":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/types\/publicaciones"}],"author":[{"embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/users\/24"}],"wp:attachment":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/media?parent=2697"}],"wp:term":[{"taxonomy":"ano","embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/ano?post=2697"},{"taxonomy":"idioma","embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/idioma?post=2697"},{"taxonomy":"etiquetas-publicacion","embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/etiquetas-publicacion?post=2697"},{"taxonomy":"categoria-publicacion","embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/categoria-publicacion?post=2697"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}